Ending the Allure of Drug Advertising

ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.

How a National Risk Pool Can Transform Gene & Cell Therapies

For patients suffering from rare, debilitating diseases, cell and gene therapies offer a source of hope. These innovative treatments are tailored to individual patients’ DNA, which makes them uniquely effective. But there is one major problem – the staggeringly high price tag.

ACHP Letter on Patent Reform

ACHP submitted a comment letter to the United States Patent and Trademark Office on double patenting, or “patent thickets.”

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow